|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
The
expression of CD154 (CD40 ligand), a member of the
Tumor Necrosis Factor gene family, by activated T lymphocytes is critical in
the development of humoral and cell-mediated
immunity. CD154 blockade retards the development and progression of immune
responses in an array of transplantation and autoimmune disease models
ranging from Systemic Lupus Erythematosus to
Rheumatoid Arthritis to Multiple Sclerosis. Overexpression
of splice isoforms of polypyrimidine
tract binding protein differentially regulate CD154 expression and mRNA
accumulation in a 3'-UTR-dependent manner in cell lines and normal human T
cells. This
technology is claimed in a pending patent application. We are seeking an
industrial partner interested in its commercialization. (Ref.:
J323) |
||
|
|
|
|
|
|
|
|
«Technology Transfer Office : Sponsored Projects : Dartmouth College |
|||
|
|
||||
|
|
||||
|
|
Phone: (603) 646-3027 |
|||
|
|
|
|
Fax: (603) 646-3670 |
|